Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

SSE:600613.SS

6.75 (CNY) • At close June 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995199419931992
Revenue 2,048.8082,340.9462,388.6182,303.0331,819.0071,927.5931,852.9061,735.7161,597.8681,592.9121,293.713929.184153.999148.25105.84176.97569.62265.95962.36269.83576.1524.24512.65536.76455.808104.786115.469266.786226.519212.041213.863178.6594.803
Cost of Revenue 1,075.0671,173.051,124.934916.697735.253709.908723.705689.982541.18413.617275.611240.0232.09131.2527.97125.81924.40523.49728.633.01622.38510.87710.90220.2725.37186.19187.224223.12193.895184.940125.65756.234
Gross Profit 973.7421,167.8961,263.6841,386.3361,083.7531,217.6851,129.2011,045.7341,056.6881,179.2961,018.102689.165121.90911777.8751.15745.21842.46233.76236.81953.76513.3671.75216.49430.43718.59528.24543.66632.62427.101213.86352.99338.569
Gross Profit Ratio 0.4750.4990.5290.6020.5960.6320.6090.6020.6610.740.7870.7420.7920.7890.7360.6650.6490.6440.5410.5270.7060.5510.1380.4490.5450.1770.2450.1640.1440.12810.2970.407
Reseach & Development Expenses 32.88532.30545.99150.94842.79119.95922.84823.87314.66820.86123.48715.0861.2460.2570.604000000000000000000
General & Administrative Expenses -53.62227.01724.62330.58837.45330.71140.25633.7539.0935.56539.54334.6135.6342.9213.04311.1719.7569.95615.01210.17121.114.99231.75937.02217.40626.01527.0235.39125.99421.81308.5253.95
Selling & Marketing Expenses 621.467826.8821,002.7081,135.951914.279882.092827.309725.35710.324778.503671.635463.52686.49784.80767.60633.327.91323.89410.42313.25517.2042.9532.3432.6452.9341.8412.4767.4294.7794.45103.6820
SG&A 567.845982.7121,027.3321,166.539951.732912.803867.564759.101749.414814.068711.178498.13892.13187.72970.64844.47237.66933.8525.43423.42638.30417.94534.10239.66720.33927.85629.49642.8230.77226.263012.2073.95
Other Expenses 281.34570.0489.11885.13377.90785.809-4.0327.33418.2044.3192.40412.1391.5861.4840.6980.7682.39810.9393.562.21813.9092.158-8.9490.26711.09323.0735.5094.8834.56210.527-5.853-4.389-0.483
Operating Expenses 882.0751,085.0571,162.441,302.6191,072.431,018.57978.847864.002848.819913.326799.272558.254104.02398.54178.74245.15638.2934.39526.2924.58639.50218.26434.37839.89921.86727.90729.62343.0930.63226.398205.13424.65914.827
Operating Income 91.66782.839105.485101.2659.44197.025129138.701194.567254.468211.764125.06816.97921.0887.938-28.2442.9424.2571.8869.23812.589-29.517-94.981-42.7799.653-14.58218.9839.82915.3622.04939.99745.93926.506
Operating Income Ratio 0.0450.0350.0440.0440.0050.1020.070.080.1220.160.1640.1350.110.1420.075-0.3670.0420.0650.030.1320.165-1.217-7.506-1.1640.173-0.1390.1640.0370.0680.1040.1870.2570.28
Total Other Income Expenses Net -4.0890.569-42.257-1.668-349.719-0.096-4.0327.3340.0844.3192.40412.139-15.9631.460.698-32.2852.3987.129-2.0262.2188.2381.699-41.288-0.023-3.33421.4490.9851.5091.0572.807-5.684-4.464-1.987
Income Before Tax 87.57883.40863.22899.597-340.278108.265124.968146.036212.754258.787214.168137.20818.55322.5488.635-27.4765.3415.1965.44611.45720.827-27.818-104.156-42.80216.196.86719.96810.99816.41824.85634.31341.47524.519
Income Before Tax Ratio 0.0430.0360.0260.043-0.1870.0560.0670.0840.1330.1620.1660.1480.120.1520.082-0.3570.0770.230.0870.1640.273-1.147-8.231-1.1640.290.0660.1730.0410.0720.1170.160.2320.259
Income Tax Expense 21.525.14915.21931.63513.19527.69626.52626.436.10240.52133.26724.0793.4483.3872.399-1.9390.4530.761.8742.7484.5670.0010.2520.9860.6341.3340.0230.7091.6991.7773.455.5213.473
Net Income 71.38857.00148.54869.623-353.47383.975106.091129.601182.06216.73180.17111.5413.70217.5545.674-23.724.38413.7912.8917.7815.096-28.038-102.914-43.6736.7056.4433.8889.63613.89321.97629.52935.28221.046
Net Income Ratio 0.0350.0240.020.03-0.1940.0440.0570.0750.1140.1360.1390.120.0890.1180.054-0.3080.0630.2090.0460.1110.198-1.156-8.133-1.1880.120.0610.0340.0360.0610.1040.1380.1970.222
EPS 0.130.110.090.13-0.660.160.20.240.340.440.40.240.20.10.033-0.130.0250.0780.0210.0380.074-0.16-0.58-0.240.0140.0320.0190.0430.0680.110.140.170.1
EPS Diluted 0.130.110.090.13-0.660.160.20.240.340.440.40.240.20.10.033-0.130.0250.0780.0210.0380.074-0.16-0.58-0.240.0140.0320.0190.0430.0680.110.140.170.1
EBITDA 194.371192.745177.025176.569-276.047177.829172.784192.474258.094297.612246.027163.342110.63232.01319.22315.70217.66417.56124.18529.06137.427-17.385-59.828-34.21420.061.56811.6090.2361.9920.703-205.13428.33423.742
EBITDA Ratio 0.0950.0820.0740.077-0.1520.0920.0930.1110.1620.1870.190.1760.7180.2160.1820.2040.2540.2660.3880.4160.491-0.717-4.728-0.9310.3590.0150.1010.0010.0090.003-0.9590.1590.25